You are here: Home » International » News » Companies
Business Standard

Lupin,Zydus Pharmaceuticals recall products in US, says USFDA report

The USFDA classified both the recalls as Class III

Press Trust of India  |  New Delhi 

Drugs, Pharma, medicine

major Lupin is recalling 46,700 bottles of Sulfate extended-release tablets, used to treat severe pain, in the US market, according to a report by the US health regulator.

is recalling the in various strengths due to "failed impurities/degradation specifications", the latest enforcement report by the US Food and Administration (USFDA) said.

"Product was shipped to five wholesalers and one who may have further distributed the product throughout the US," it added.

Zydus Pharmaceuticals USA Inc, a subsidiary of Zydus Cadila, is also recalling 7,668 bottles of Carvedilol Tablets, used to treat high blood pressure, in the American market.

The drug firm is recalling the drug due to the "presence of foreign tablets/capsules", the USFDA said.

"Customer complaint for a small, solid, light yellow substance, identified as a fragmented tablet of another drug product, found mixed with tablets in a bottle of 3.125mg," it added.

The USFDA classified both the recalls as

A recall by the USFDA is initiated in a situation in which use of or exposure to a is not likely to cause adverse health consequences.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

First Published: Sun, May 05 2019. 10:35 IST